CV

+ Watchlist + Portfolio

CapsoVision, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $6.12
52-Week Range: $3.43 – $15.37
Market Cap: $295.78M
P/E (TTM): —
EPS (TTM): -1.11
Dividend Yield: —

Advanced Metrics

Price/Book: 22.47
PEG Ratio: —
Return on Equity: -335.06%
Return on Assets: -132.47%
Gross Margin: 50.88%
Operating Margin: -208.07%
Profit Margin: -214.74%
Current Ratio: 3.35
Debt/Equity: 0.05
Total Debt: $687.00K
Free Cash Flow: $-16.28M
Revenue Growth: 9.90%
Earnings Growth: —
Enterprise Value: $297.90M

CV Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Revenue	$9.75M	$11.76M	$13.55M
Cost of Revenue	$4.26M	$5.38M	$6.38M
Gross Profit	$5.49M	$6.38M	$7.17M
Research & Development	$9.33M	$15.12M	$18.31M
Selling, General & Admin	$7.50M	$11.17M	$14.38M
Operating Expenses	$16.84M	$26.29M	$32.69M
Operating Income	-$11.35M	-$19.92M	-$25.52M
EBITDA	-$10.96M	-$19.40M	-$24.95M
Pretax Income	-$11.29M	-$19.89M	-$25.29M
Income Tax	$11.00K	$11.00K	$24.00K
Net Income	-$11.30M	-$19.90M	-$25.32M
Diluted EPS	-0.29	-0.43	-1.03
Diluted Shares	38.62M	46.34M	46.87M

CV Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Cash & Equivalents	$14.56M	$9.32M	$10.11M
Receivables	$1.87M	$2.00M	$2.50M
Inventory	$2.19M	$2.63M	$2.99M
Current Assets	$19.20M	$14.85M	$16.67M
Total Assets	$21.53M	$16.80M	$18.16M
Current Liabilities	$1.51M	$1.80M	$4.43M
Total Debt	$1.51M	$1.24M	$887.00K
Total Liabilities	$131.37M	$146.31M	$4.90M
Retained Earnings	-$110.45M	-$130.35M	-$155.66M
Shareholders' Equity	-$109.84M	-$129.51M	$13.26M
Working Capital	$17.70M	$13.05M	$12.24M

CV Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Operating Cash Flow	-$10.80M	-$20.09M	-$22.86M
Capital Expenditure	-$754.00K	-$153.00K	-$90.00K
Free Cash Flow	-$11.56M	-$20.24M	-$22.95M
Depreciation & Amortisation	$388.00K	$521.00K	$567.00K
Stock-Based Compensation	$43.00K	$156.00K	$826.00K
Investing Cash Flow	-$754.00K	-$153.00K	-$90.00K
Financing Cash Flow	$20.53M	$15.07M	$23.60M
Net Change in Cash	$8.97M	-$5.17M	$650.00K

CV Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$2.78M	$3.31M	$3.54M	$3.92M	$2.79M
Cost of Revenue	$1.29M	$1.50M	$1.62M	$1.96M	$1.46M
Gross Profit	$1.49M	$1.81M	$1.91M	$1.95M	$1.33M
Research & Development	$3.11M	$3.39M	$6.09M	$5.72M	$4.43M
Selling, General & Admin	$3.77M	$3.07M	$3.84M	$3.70M	$3.99M
Operating Expenses	$6.88M	$6.46M	$9.93M	$9.42M	$8.42M
Operating Income	-$5.38M	-$4.65M	-$8.02M	-$7.46M	-$7.09M
EBITDA	-$5.25M	-$4.51M	-$7.88M	-$7.32M	-$6.94M
Pretax Income	-$5.38M	-$4.63M	-$7.92M	-$7.37M	-$7.03M
Income Tax	$0.00	$0.00	$0.00	$24.00K	$0.00
Net Income	-$5.38M	-$4.63M	-$7.92M	-$7.39M	-$7.03M
Diluted EPS	-0.12	-0.10	-0.17	—	-0.15
Diluted Shares	46.34M	46.34M	46.22M	—	47.46M

CV Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$4.40M	$1.07M	$17.79M	$10.11M	$17.93M
Receivables	$1.64M	$1.85M	$1.87M	$2.50M	$1.93M
Inventory	$3.04M	$3.04M	$3.19M	$2.99M	$3.49M
Current Assets	$10.59M	$7.80M	$24.05M	$16.67M	$24.50M
Total Assets	$12.45M	$9.55M	$25.66M	$18.16M	$25.95M
Current Liabilities	$2.73M	$4.22M	$4.63M	$4.43M	$5.36M
Total Debt	$1.15M	$2.07M	$978.00K	$887.00K	$788.00K
Total Liabilities	$3.52M	$148.53M	$5.22M	$4.90M	$5.72M
Retained Earnings	-$135.72M	-$140.35M	-$148.27M	-$155.66M	-$162.70M
Shareholders' Equity	$8.93M	-$138.99M	$20.44M	$13.26M	$20.22M
Working Capital	$7.86M	$3.58M	$19.41M	$12.24M	$19.14M

CV Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$4.99M	-$4.53M	-$5.67M	-$7.69M	-$6.07M
Capital Expenditure	-$40.00K	-$30.00K	-$12.00K	-$8.00K	-$48.00K
Free Cash Flow	-$5.03M	-$4.56M	-$5.68M	-$7.69M	-$6.11M
Depreciation & Amortisation	$137.00K	$141.00K	$143.00K	$146.00K	$150.00K
Stock-Based Compensation	$152.00K	$170.00K	$307.00K	$197.00K	$334.00K
Investing Cash Flow	-$40.00K	-$30.00K	-$12.00K	-$8.00K	-$48.00K
Financing Cash Flow	$34.00K	$1.17M	$22.39M	$15.00K	$13.95M
Net Change in Cash	-$4.99M	-$3.39M	$16.71M	-$7.68M	$7.84M

Market Snapshot

About

CapsoVision, Inc. is a medical device company specializing in capsule endoscopy technology for gastrointestinal diagnostics. Headquartered in Saratoga, California, the company manufactures and markets the CapsoCam Plus system, a wireless capsule camera that patients swallow to capture images of the small intestine. The device uses four cameras to provide 360-degree panoramic views, differentiating it from single-camera competitors. CapsoVision's technology is used by gastroenterologists to diagnose conditions such as Crohn's disease, gastrointestinal bleeding, and small bowel tumors.